Business Context and Reporting Period
This Form 8-K is a current report filed by Anthem, Inc. (now Elevance Health, Inc.) on October 1, 2019. The filing reports a corporate governance event regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statement data.
Material Changes
The material change reported is the election of Ryan Schneider as an independent director of the Company, effective immediately on October 1, 2019. His term is set to expire at the 2022 annual meeting of shareholders. Additionally, Mr. Schneider was appointed to the Audit Committee.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding business performance. It notes that Mr. Schneider will receive compensation in accordance with the Company's standard program for non-employee directors, as detailed in a previous Form 10-Q. The filing confirms there are no undisclosed arrangements or material interests related to his election.
Investor Verification Checklist
- Verify the effective date of Ryan Schneider's directorship (October 1, 2019).
- Confirm his appointment to the Audit Committee.
- Review the standard compensation program for non-employee directors referenced in the June 30, 2019 Form 10-Q (Exhibit 10.7).
- Check for any subsequent filings regarding the 2022 annual meeting of shareholders.